Neogen Chemicals Ltd Q3 FY2023 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/v9g0qzqerepm678c3swbl9yd.pdf

Key Takeaways


Battery Chemicals: Capacity, Structure & Strategy

Dr. Harin Kanani: "What we have said so far is, first of all, in the battery materials, we have only assumed India electrolyte demand currently. Of course, we keep the international demand as a backup, but we have not taken any significant number from that into our projections."

Customer Traction & Competitive Positioning

Dr. Harin Kanani: "Several of these customers have started evaluating Neogen samples and some of them have given very positive feedback that, the first samples submitted by us meet majority of their criteria. This is for both, our electrolyte as well as international salt customers with whom we have worked."

Existing Business Performance


Margins & Cost Structure

Dr. Harin Kanani: "When we are doing all three together, we feel that it is similar to basically making bromine derivatives, making advanced intermediates and then doing CSM on an OEM basis. So, that is why we feel it has a similar margin profile."

Lithium Price & Raw Material Outlook

Dr. Harin Kanani: "What we are estimating is that when the dust settles and when lithium demand-supply is balanced, it might be 2x or 3x of what were historical lithium prices. That transition when it will happen, that is very difficult to predict. Will it happen in 2 years, will it take 4 years, or will it take 6 years to reach those levels is very difficult to predict."

Guidance & Commitments

CommitmentSpecificsTimeline
Organic chemicals capacity completionRemaining 45,000 litres commissionedBy September 2023
Inorganic chemicals capacity doubling1,200 MT to 2,400 MT at DahejBy May/June 2023
Battery chemicals pilot capacity400 MTPA specialty lithium salts and additivesBy June 2023
Electrolyte pilot plant1,000 MT at Dahej SEZBy August/September 2023
Electrolyte capacity expansion5,000 MT operationalBy June 2024
Specialty lithium salts expansion1,000 MT operationalBy June 2024
Greenfield expansionAdditional 5,000 MT electrolyte and 1,000 MT specialty lithium saltsBy September 2025
Consolidated revenue target₹2,000–2,250 crore (>30% revenue CAGR)By FY26/FY27
Existing business revenue₹1,000–1,200 croreBy FY26/FY27
FY24 revenue₹700–750 crore (standard lithium price); ~₹800–850 crore (current lithium price)FY24
CSM revenue contribution20% of revenue (from ~15% currently)By FY24
Working capital cycle120–125 daysBy FY24
ROE and ROCEMuch above 20% when CAPEX fully utilizedBy FY27
Overall CAPEX funding~₹450 crore, debt-equity below 1.25xAcross FY24–FY25
EBITDA run rateTargeted ₹110 crore; run rate suggests overshootingFY23

Key Metrics

MetricQ3 FY23
Revenue₹186.3 cr, +40% YoY
9M FY23 revenue₹482.3 cr, +46% YoY
EBITDA₹30.1 cr, +27% YoY
9M FY23 EBITDA₹79 cr, +32% YoY
PAT₹14.7 cr, +40% YoY
9M FY23 PAT₹35.7 cr, +23% YoY
Organic chemicals revenue₹136 cr, +30% YoY
Inorganic chemicals revenue₹50 cr, +85% YoY
Domestic/export mix47% / 53%
CSM revenue contribution~15% of revenues in FY23; target 20% by FY24
CSM customers>39 engaged, 8 new added in 9M FY23
CSM pipeline23 products, combined revenue potential of ₹2,100 cr
Organic reactor capacity466,000 litres (466 m3) total; 15,000 litres commissioned, 45,000 litres by Sep 2023
Inorganic capacity expansion1,200 MT to 2,400 MT (30 m3 reactor), commissioning by May/Jun 2023
Battery chemicals capacity (specialty lithium salts)400 MTPA (92 m3), commissioning by Jun 2023
Electrolyte pilot capacity1,000 MT (enhanced from 250 MT), ready by Aug/Sep 2023
Electrolyte capacity expansion (brownfield)5,000 MT, operational by Jun 2024
Specialty lithium salts capacity expansion1,000 MT (232 m3), operational by Jun 2024
Electrolyte capacity expansion (greenfield)Additional 5,000 MT, total installed 10,000 MT, operational by Sep 2025
Specialty lithium salts capacity expansion (greenfield)Additional 1,000 MT, total installed ~2,000 MT, operational by Sep 2025
Total CAPEX for new projects₹450 cr, funded 70–75% debt, balance internal accruals and equity
Debt-equity ceilingBelow 1.25x
Consolidated revenue target₹2,000–2,250 cr by FY26/FY27, >30% revenue CAGR from FY22 base of ₹487 cr
Battery chemicals revenue target₹1,000–1,200 cr from battery chemicals division
Existing business revenue potential by FY27₹1,050 cr, implying 13–15% CAGR
FY24 revenue target₹700–750 cr on standard lithium price; ~₹800–850 cr at current lithium price
EBITDA margin expectation (battery chemicals)18.5% ±1%; base case 17.5% in models
Gross margin range42% ±2% (40–44% on stable basis)
ROE/ROCE projection (fully utilized by FY27)Much above 20%
Working capital cycle target120–125 days by FY24
FY23 EBITDA target₹110 cr; run rate suggests overshooting
Lithium price context6x–8x historical levels; expected to settle at 2x–3x